A number of preliminary studies have reported that the correction of low Hb concentrations using erythropoiesis-stimulating proteins (ESPs) may improve cardiac and renal function and reduce the requirement for hospitalization and diuretics in patients with CHF (9–10). This evidence concerns the gene GSTM1 and congestive heart failure.